The Journal of Alzheimer’s Disease Partners with ÜberResearch

The Journal of Alzheimer’s Disease  (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology of Alzheimer’s disease (AD).  Today, JAD announced that its Alzheimer’s Funding Analyzer (AFA) now includes all Alzheimer’s Association grants in addition to grants from other funding bodies. AFA is a free service that is part of a suite of online features integrated into the JAD site to meet the needs of the AD research community. JAD is published by IOS Press.

AFA includes all funding related to AD drawn from our portfolio company  ÜberResearch’s extensive grant database of more than $1.1 trillion of funded research, representing more than 3.4 million projects from 258 different funders like the National Institutes of Health and the National Science Foundation in the U.S. and the Wellcome Trust and U.K. Research Councils in the U.K.

There are currently 1,080 Alzheimer’s Association grants represented on the site with an aggregated funding amount of $189.5 million and average funding amount of $175,000.

JAD’s Editor-in-Chief George Perry, PhD, Dean and Professor of Biology, The University of Texas at San Antonio says:

“Now expanded with inclusion of Alzheimer’s Association grants, we are very excited to provide this comprehensive listing of the funding that has made progress possible, which can be studied to understand how Alzheimer’s disease research is developing,”

Christian Herzog, CEO of ÜberResearch adds:

“ÜberResearch is honored to collaborate with our friends at JAD and the Alzheimer’s research community. We hope to provide more information on global funding, support better research decisions, and expedite the development of treatments and the search for a cure.” 

Free registration on JAD not only enables users to access AFA, but also to use other features on the site. You can learn more about this news here.